Ancora Pharmaceuticals
Ancora Pharmaceuticals developed synthetic carbohydrate-based therapeutics and vaccines, acquired by CordenPharma in October 2013.
- 75
- Medford, MA, USUnited States
Ancora Pharmaceuticals developed synthetic carbohydrate-based therapeutics and vaccines, acquired by CordenPharma in October 2013.
CordenPharma provides an integrated solution spanning product life cycle stages from preclinical to commercial, supported by regulatory and project management services.
The company offers formulation and process development from early phases through late phases, as well as commercial Drug Product supply.
The company provides a generic API list.
Dr. Stephen Houldsworth discusses expansions in small molecule API capacity & Drug Product tablet & capsule manufacturing across CordenPharma facilities.
The pharmaceutical and biopharma industry is growing amid consolidation, mergers and acquisitions, and the emergence of start-ups and academic technology spin-offs. The page also notes a trend toward outsourcing APIs and drug products to CDMOs.
CordenPharma's work environment fosters diversity, inclusion, and personal career development.
CordenPharma is hiring engineers, operators, and supply chain managers for peptide pharma jobs in Boulder, Colorado.
CordenPharma offers pharmaceutical job and career opportunities and describes its team as global.
CordenPharma is a full-service CDMO for the global market, providing expert support for the development and manufacturing of APIs, Excipients, Drug Products, and associated Packaging Services.
CordenPharma's Code of Conduct sets standards for ethical behavior and integrity across its operations.
CordenPharma culture is built on values of integrity, accountability, trust, collaboration & reliability with a focus on diversity, career growth & ESG.
CordenPharma's mission & vision is to support global Pharmaceutical & Biotechnology customers with high-quality products for the well-being of patients.
CordenPharma provides CDMO support for pharmaceutical supply chains involving drug substances, drug products, excipients, and LNP formulations.
CordenPharma is a leading CDMO for cGMP development & manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligos, & osd.
The company collects comment-form data, visitors’ IP addresses, and browser user-agent strings to help detect spam.
General Terms and Conditions of Purchase Corden Pharma Bergamo